Urodynamic effects of dutasteride add-on therapy to alpha-adrenergic antagonist for patients with benign prostatic enlargement: Prospective pressure-flow study-Reference-Cited by-同舟云学术

Urodynamic effects of dutasteride add-on therapy to alpha-adrenergic antagonist for patients with benign prostatic enlargement: Prospective pressure-flow study

Published:2013-07-17 Issue:8 Volume:32 Page:1123-1127
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourol. Urodynam.

Author:

Wada Naoki¹,Kita Masafumi¹,Hashizume Kazumi¹,Matsumoto Seiji¹,Kakizaki Hidehiro¹

Affiliation:

1. Department of Renal and Urologic Surgery; Asahikawa Medical University; Asahikawa Japan

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/nau.22349/fullpdf

Reference27 articles.

1. The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-Year results from Combination of Avodart and Tamsulosin Study;Becher;Prostate Cancer Prostatic Dis,2009

2. The effect of dutasteride on voiding and storage symptoms in men with benign prostatic hyperplasia;Tsukamoto;Acta Urol Jpn,2010

3. Comparison of two α1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: A randomized crossover study;Nishino;BJU Int,2006

4. Efficacy of silodosin for relieving benign prostatic obstruction: Prospective pressure flow study;Matsukawa;J Urol,2009

5. Urodynamic effects of silodosin, a new α1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia;Yamanishi;Neurourol Urodyn,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling study of the effect of placebo and medical therapy on storage and voiding symptoms, nocturia, and quality of life in men with prostate enlargement at risk for progression;Prostate Cancer and Prostatic Diseases;2023-10-04

2. Efficacy and safety of dutasteride with tadalafil add-on therapy in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia;BMC Research Notes;2022-09-05

3. Dutasteride add-on treatment to tadalafil for patients with benign prostatic enlargement is similarly effective as dutasteride add-on treatment to alpha blocker: a propensity-score matching analysis;International Urology and Nephrology;2022-04-01

4. The cutoff value of transitional zone index predicting the efficacy of dutasteride on subjective symptoms in patients with benign prostate hyperplasia;LUTS: Lower Urinary Tract Symptoms;2022-02-16

5. Risk factors for failure of long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with lower urinary tract symptoms and benign prostatic enlargement;International Urology and Nephrology;2021-11-12